Pyrotinib for Elderly Patients with Advanced HER2-Positive Breast Cancer

INTRODUCTION: According to the latest global cancer data released by WHO in 2020, the incidence of breast cancer (BC) has been the most prevalent, and the mortality rate of female malignant tumor ranks the first. METHODS: To evaluate toxicity and efficacy regarding oral Pyrotinib for elderly patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan, Ma, Xiaoping, Zhao, Zhenhui, Li, Li, Gao, Chunyan, Liu, Dan, Li, Bingyu, Zhao, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739962/
https://www.ncbi.nlm.nih.gov/pubmed/36510611
http://dx.doi.org/10.2147/BCTT.S383272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739962/
https://www.ncbi.nlm.nih.gov/pubmed/36510611
http://dx.doi.org/10.2147/BCTT.S383272

Ejemplares similares